Gene transfer and the treatment of haematological malignancy

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Gene therapy offers an additional therapeutic modality for treating haematological malignancy. Because gene therapies could be truly specific for the malignancy, they should ultimately prove both safe and effective. We have far to go before this full potential is realized, but gene transfer strategies are already showing therapeutic promise. Gene transfer may be used to correct the genetic defect in the tumour, to render it more susceptible to conventional therapies, or the normal host cells more resistant, to induce or amplify an antitumour immune response, or simply as a means of tracking the tumour or cells used for treatment. This article describes examples of each approach and discusses future prospects for the field.

Original languageEnglish (US)
Pages (from-to)345-358
Number of pages14
JournalJournal of Internal Medicine
Volume249
Issue number4
DOIs
StatePublished - 2001

Keywords

  • Cytotoxic T cell
  • Gene transfer
  • Leukaemia

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Gene transfer and the treatment of haematological malignancy'. Together they form a unique fingerprint.

Cite this